HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- cyclohexyl- N3- (2- (3- fluorophenyl)ethyl)- N- (2- ((2- (4- hydroxy- 2- oxo- 2,3- dihydro- 1,3- benzothiazol- 7- yl)ethyl)amino)ethyl)- beta- alaninamide

structure in first source

Also Known As:

AZD9708

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Alanine: 4133
    - beta-Alanine: 172
      - N-cyclohexyl-N3-(2-(3-fluorophenyl)ethyl)-N-(2-((2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl)amino)ethyl)-beta-alaninamide: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Benzothiazoles: 40
        N-cyclohexyl-N3-(2-(3-fluorophenyl)ethyl)-N-(2-((2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl)amino)ethyl)-beta-alaninamide: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzothiazoles: 40
      - N-cyclohexyl-N3-(2-(3-fluorophenyl)ethyl)-N-(2-((2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl)amino)ethyl)-beta-alaninamide: 2

Experts

1.	Fred, Charlotta: 1 article (03/2013)
2.	Mutch, Peter: 1 article (03/2013)
3.	Nicholls, David J: 1 article (03/2013)
4.	O'Donovan, Michael R: 1 article (03/2013)
5.	Pohl, Cecilia Diaz: 1 article (03/2013)
6.	Pontén, Ingrid: 1 article (03/2013)
7.	Saad, Alaa: 1 article (03/2013)
8.	Young, Alan: 1 article (03/2013)
9.	Åberg, Per: 1 article (03/2013)
10.	Austin, R P: 1 article (08/2012)

Related Diseases

1.	Chronic Obstructive Pulmonary Disease (COPD) 08/01/2012 - "Here we describe the pre-clinical pharmacological profile of AZD9708, a novel long-acting β(2)-adrenoceptor agonist that has potential as a once-daily therapy for asthma and chronic obstructive pulmonary disease (COPD). "
2.	Respiratory Tract Diseases (Respiratory Tract Disease) 03/01/2013 - "AZD9708 is a new chemical entity with selective and long-acting β2-agonistic properties currently being evaluated by AstraZeneca for potential use in treatment of respiratory diseases by the inhaled route. "
3.	Asthma (Bronchial Asthma) 08/01/2012 - "Here we describe the pre-clinical pharmacological profile of AZD9708, a novel long-acting β(2)-adrenoceptor agonist that has potential as a once-daily therapy for asthma and chronic obstructive pulmonary disease (COPD). "

Related Therapies and Procedures

1.	Therapeutics